000 01537nam a2200385 i 4500
999 _c289120
_d289120
001 on1121594536
003 OCoLC
005 20191203084832.0
006 m o d f
007 cr mn|||||||||
008 191003s2019 dcua ob f000 0 eng c
040 _aPUCPR
_beng
_erda
_epn
_cGPO
_dMvI
042 _apcc
043 _an-us---
074 _a0718-C-01 (online)
086 0 _aJ 37.2:D 84
099 _aJ 37.2:D 84
110 1 _aUnited States.
_bDepartment of Justice.
_bEvaluation and Inspections Division,
245 1 0 _aReview of the Drug Enforcement Administration's regulatory and enforcement efforts to control the diversion of opioids.
264 1 _a[Washington, D.C.] :
_bOffice of the Inspector General, U.S. Department of Justice, Evaluation and Inspections Division,
_c2019.
300 _a1 online resource (iv, 71 pages), color illustrations
336 _btxt
337 _bc
_2rdamedia
338 _bcr
_2rdacarrier
500 _a"Evaluation and Inspections Division 19-05."
500 _a"September 2019."
500 _aCRDP Program record.
504 _aIncludes bibliographical references.
588 _aDescription based on online resource, PDF version; title from title page (OIG, viewed October 3, 2019).
856 4 0 _uhttps://purl.fdlp.gov/GPO/gpo126560
610 1 0 _aUnited States.
_bDrug Enforcement Administration
_xEvaluation.
650 0 _aOpioid abuse
_zUnited States.
650 0 _aDrug control
_zUnited States.
942 _2sudocs
_c8